Arcellx, Inc. (ACLX) Dividend History

Arcellx, Inc. (ACLX) is a biotechnology company focused on developing innovative cell therapy platforms for cancer and other diseases. It specializes in engineered cell therapies, including its proprietary Axicabtagene ciloleucel (AXC) product, aimed at advancing personalized immuno-oncology treatments. The company leverages its unique, modular cell engineering platform to create targeted, flexible, and potent therapeutic options.

800 Bridge Parkway, Redwood City, CA, 94065
Phone: 240-327-0603
Website: https://www.arcellx.com

Dividend History

Arcellx, Inc. currently does not pay dividends

Company News

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

The article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.

Benzinga

Featured Companies: AKYA ONCY QTRX TCRX
Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. Increasing adoption of CAR-T cell therapies, monoclonal antibodies, and personalized medicine is transforming treatment outcomes.

GlobeNewswire Inc.

Featured Companies: ABBV ADCT BMY JNJ KROS MRK REGN SLS
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates

Arcellx (ACLX) delivered earnings and revenue surprises of 72.55% and 32.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research
Wall Street Breakfast: The Week Ahead

Get the latest financial updates and insights with Wall Street Breakfast's daily podcast available on Seeking Alpha, iTunes, and Spotify.

Seeking Alpha

Featured Companies: ABM ACM ADBE AFRM AGIO AMT BASE BMY CASY CAVA CHWY CNC COST CRSP CRVS DDC DRI INAB INCY INTC JBL JCI LEN LHX LLY ORCL PFE RIGL SDGR SGN SHIM STTK VOR WDFC WEC
ASCO 2022: Surprising News in Cancer Research

The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.

The Motley Fool

Featured Companies: ADPT BMY GILD JNJ LGND

Page data last updated 07/23/2025 16:08:12 UTC